文献速递炎症性肠病

炎症性肠病特异性认知行为疗法通过远程医疗减轻残疾:一项以心理社会远程医疗有效应对残疾的实用性随机对照试验

Inflammatory Bowel Diseases-Specific Cognitive Behavioral Therapy Delivered Through Telehealth Reduces Disability: Addressing Disability Effectively With Psychosocial Telemedicine Pragmatic Randomized Controlled Trial.
PubMed 文献 · Am J Gastroenterol · 2025-07-30

这项开放标签、多中心1:2随机对照试验纳入90例中度至重度IBD相关残疾成人,比较8周远程医疗递送IBD特异性CBT与常规护理。CBT组IBD-DI残疾评分显著降低(β=5.9,P=0.02),临床相关改善的校正OR为2.9(95%CI 1.0-8.2,P=0.04);临床疾病活动度及直接和间接费用两组无差异。

要点

  • 8周远程IBD特异性CBT可降低IBD相关残疾,β=5.9(P=0.02)。
  • 临床相关改善的校正OR为2.9(95%CI 1.0-8.2,P=0.04)。
  • 临床疾病活动度及IBD直接和间接费用两组无差异。

核心结论

  • 在IBD患者随机对照试验中,8周远程医疗递送IBD特异性CBT方案减轻了IBD相关残疾,且独立于临床疾病活动度。

研究设计与样本

  • 开放标签、多中心1:2随机对照试验(NCT05635292),纳入中度至重度IBD相关残疾成人,比较8周远程医疗递送CBT与常规护理。
  • 2023年2月至10月在美国5家参与克罗恩病与结肠炎基金会临床研究联盟的消化科诊所招募,共随机90例。
  • 基线及第8周收集临床、人口学、疾病活动度和心理数据;主要终点为校正IBD亚型和疾病活动度后的IBD-DI评分绝对变化。

主要发现

  • 90例随机患者中74.4%为克罗恩病、25.6%为溃疡性结肠炎、76.7%临床活动;74例(82.2%)完成试验,69例(76.6%)坚持8周远程治疗方案。
  • 远程治疗组残疾显著降低(β=5.9,P=0.02),临床相关改善的校正OR为2.9(95%CI 1.0-8.2,P=0.04),对照为常规护理组。
  • IBD临床疾病活动度及IBD直接和间接费用两组间无差异。

关键数值与推荐

  • 主要终点为IBD-DI评分绝对变化,临床相关改善定义为IBD-DI下降17分。
  • 远程治疗组较对照组残疾降低β=5.9(P=0.02),临床相关改善校正OR=2.9(95%CI 1.0-8.2,P=0.04)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Inflammatory bowel disease (IBD)-related disability encompasses physical and psychosocial dimensions, and it is under-recognized and under-treated in patients with IBD. Cognitive behavioral therapy (CBT) is a structured, time-limited, and problem-focused psychotherapy that targets inaccurate thoughts and maladaptive behaviors. We aimed to investigate the effect of IBD-specific CBT delivered through telehealth on disability in patients with IBD. METHODS: "Addressing Disability Effectively with Psychosocial Telemedicine" (NCT05635292) was an open-label, multicenter 1:2 randomized controlled trial for adults with moderate-to-severe IBD-related disability (assessed by the IBD Disability Index [IBD-DI]) to receive 8 weeks of telehealth-delivered CBT or usual care. Recruitment occurred between February and October 2023 at 5 gastroenterology clinics in the United States participating in the Crohn's & Colitis Foundation's Clinical Research Alliance. Clinical, demographic, disease activity, and psychological data were collected at baseline and at week 8. The primary end point was changes in IBD-DI (absolute change in IBD-DI score; clinically relevant improvement of 17-point decrease in IBD-DI), adjusted for IBD subtype and disease activity. The secondary outcomes were differences in direct and indirect costs between groups. Changes in IBD clinical disease activity was an exploratory end point. RESULTS: Ninety patients were randomized (74.4% Crohn's disease; 25.6% ulcerative colitis; 76.7% clinically active), of which 74 (82.2%) completed the trial and 69 (76.6%) adhered to the 8-week teletherapy protocol. Teletherapy group had significantly reduced disability (β = 5.9, P = 0.02) and clinically relevant improvements (adjusted odds ratio 2.9, 95% confidence interval 1.0-8.2 P = 0.04) compared with controls. Clinical disease activity and the cost of IBD (both direct and indirect) did not differ between the 2 groups. DISCUSSION: In a randomized controlled trial of patients with IBD, an 8-week telehealth-delivered IBD-specific CBT protocol reduced IBD-related disability, independent of clinical disease activity.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Tse CS, Lewis JD, Horst SN, et al. Inflammatory Bowel Diseases-Specific Cognitive Behavioral Therapy Delivered Through Telehealth Reduces Disability: Addressing Disability Effectively With Psychosocial Telemedicine Pragmatic Randomized Controlled Trial. Am J Gastroenterol. 2025. PMID: 40736700. doi:10.14309/ajg.0000000000003681

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。